Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CSGP4—specific chimeric antigen receptor for cancer

CSGP4—specific chimeric antigen receptor for cancer

US Patent 11725061 · Granted Aug 15, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for chimeric antigen receptor targeting cancer cells2025
Methods and compositions for chimeric antigen receptor targeting cancer cells2025
Highly modular biepitopic and bispecific CAR-T cells for cancer immunotherapy2025
Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof2021
Antibodies to endoplasmin and their use2021
Anti-CSPG4 reagents and methods of treating cancer2021
Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses2020
Methods and compositions for chimeric antigen receptor targeting cancer cells2019
Methods and compositions for chimeric antigen receptor targeting cancer cells2019
Methods and compositions for chimeric antigen receptor targeting cancer cells2019
Methods and compositions for chimeric antigen receptor targeting cancer cells2019
Combination treatments with sonic hedgehog inhibitors2019